Kintsugi, a San Francisco-based AI-driven tax compliance startup, has secured $18 million in new funding, doubling its valuation to $150 million within six months. The funding round was led by Vertex ...
Raymond James analyst Christopher Raymond initiated coverage of Vertex Pharmaceuticals (VRTX) with a Market Perform rating and no price target Vertex has “arguably been one of biotech’s best execution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback